Asthma Control Test Guided Treatment in Chinese Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

530

Participants

Timeline

Start Date

August 26, 2016

Primary Completion Date

August 9, 2019

Study Completion Date

August 9, 2019

Conditions
Asthma
Interventions
DRUG

ACT guided Routine Treatment

The ACT is a validated, short, easy to use, and self-administered instrument used to assess asthma control. Subjects in this group received routine treatment as per ACT score.

DRUG

Routine Treatment

Subjects in the controlled treatment group will receive usual care of asthma. This treatment was monitored and adjusted as usual by the patient's general practitioner.

Trial Locations (6)

200032

GSK Investigational Site, Shanghai

200052

GSK Investigational Site, Shanghai

200135

GSK Investigational Site, Shanghai

201299

GSK Investigational Site, Shanghai

201700

GSK Investigational Site, Shanghai

Unknown

GSK Investigational Site, Shanghai

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

MacroStat

OTHER

lead

GlaxoSmithKline

INDUSTRY

NCT02868281 - Asthma Control Test Guided Treatment in Chinese Subjects | Biotech Hunter | Biotech Hunter